Biomarin Pharmaceutical (BMRN) Current Deferred Tax Assets (2010 - 2015)
Biomarin Pharmaceutical's Current Deferred Tax Assets was $30.88 million in Q3 2015, up 5.9% from $29.15 million a year earlier but down 1.0% from the prior quarter.
Biomarin Pharmaceutical (BMRN) Current Deferred Tax Assets (2010 - 2015) Analysis & Trends
At the end of FY2014, Current Deferred Tax Assets at Biomarin Pharmaceutical came in at $31.2 million, up 2.1% from FY2013.
- Current Deferred Tax Assets shows a four-year compound annual growth rate of 17.0% (FY2010 to FY2014).
- In earlier years, Current Deferred Tax Assets was $30.56 million in FY2013 (-5.5%), $32.36 million in FY2012 (+53.2%), $21.12 million in FY2011 (+26.8%) and $16.66 million in FY2010.
- Quarterly Current Deferred Tax Assets has moved between $16.66 million (Q4 2010) and $32.36 million (Q4 2012) over five years.
- Compared with a year earlier, Current Deferred Tax Assets has increased for four straight quarters, with growth averaging 0.6% over the last eight quarters.
- The best year-over-year quarter for Current Deferred Tax Assets over five years was Q4 2012 (growth of 53.2%); the worst was Q3 2014 (a decline of 9.6%).
- Per Business Quant data, BMRN's Current Deferred Tax Assets in the three quarters before Q3 2015 was $31.2 million (Q2 2015), $31.2 million (Q1 2015) and $31.2 million (Q4 2014).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Biomarin Pharmaceutical | 11.61 Bn | 5.48 Bn | 786.91 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2015 | 30.88 Mn |
| Jun 30, 2015 | 31.20 Mn |
| Mar 31, 2015 | 31.20 Mn |
| Dec 31, 2014 | 31.20 Mn |
| Sep 30, 2014 | 29.15 Mn |
| Jun 30, 2014 | 30.56 Mn |
| Mar 31, 2014 | 30.56 Mn |
| Dec 31, 2013 | 30.56 Mn |
| Sep 30, 2013 | 32.24 Mn |
| Jun 30, 2013 | 29.47 Mn |
| Mar 31, 2013 | 29.47 Mn |
| Dec 31, 2012 | 32.36 Mn |
| Sep 30, 2012 | 23.95 Mn |
| Jun 30, 2012 | 21.12 Mn |
| Mar 31, 2012 | 21.12 Mn |
| Dec 31, 2011 | 21.12 Mn |
| Sep 30, 2011 | 16.66 Mn |
| Jun 30, 2011 | 16.66 Mn |
| Dec 31, 2010 | 16.66 Mn |
Biomarin Pharmaceutical Current Deferred Tax Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=BMRN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-tax-assets", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();